Atlas Trials

Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes

Clinical trial NCT00129259 · COMPLETED

Trial details

NCT number
NCT00129259
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 1
Start date
2005-09-01
Primary completion
2011-03-01
Enrollment
83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.